In AML with NK, about 45% of BCOR-mutated AML have co-mutations with DNMT3A and/or RUNX1, while being mutually exclusive with NPM1 and FLT3 mutations [50,51]. This evidence concerns the gene FLT3 and acute myeloid leukemia.